Cargando…
Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma
Metastatic melanoma remains one of the most lethal and poorly treated forms of human cancer. Its incidence is on the rise, but no therapies offering improved survival rates have been developed over the last 40 years. This has changed with the recent Food and Drug Administration (FDA) approval of the...
Autor principal: | Mansh, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238313/ https://www.ncbi.nlm.nih.gov/pubmed/22180676 |
Ejemplares similares
-
Cancer Immunotherapy Takes a Multi-Faceted Approach to Kick the Immune System into Gear
por: Dimberu, Peniel M., et al.
Publicado: (2011) -
Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy
por: Flies, Dallas B., et al.
Publicado: (2011) -
Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022) -
Nanoparticle Delivery of Anti-Tuberculosis Chemotherapy as a Potential Mediator Against Drug-Resistant Tuberculosis
por: Smith, Jonathan Paul
Publicado: (2011) -
Introduction
por: Zhao, Peter, et al.
Publicado: (2011)